Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
Jean‐Daniel Lalau, Abdallah Al‐Salameh, Samy Hadjadj, Thomas Goronflot, Nicolas Wiernsperger, Matthieu Pichelin, Ingrid Allix, Coralie Amadou, Olivier Bourron, Thierry Duriez, Jean–François Gautier, Anne Dutour, Céline Gonfroy, D. Gouet, Michaël Joubert, Ingrid Julier, Étienne Larger, Lucien Marchand, Michel Marre, Laurent Meyer, Frédérique Olivier, Gaëtan Prévost, Pascale Quiniou, Christelle Raffaitin‐Cardin, Ronan Roussel, Pierre‐Jean Saulnier, Dominique Seret‐Bégué, Charles Thivolet, Camille Vatier, Rachel Desailloud, Matthieu Wargny, Pierre Gourdy, Bertrand Cariou
Topics & Concepts
MetforminMedicineCoronavirus disease 2019 (COVID-19)Diabetes mellitus2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineIntensive care medicineEmergency medicineEndocrinologyVirologyDiseaseOutbreakInfectious disease (medical specialty)Metabolism, Diabetes, and CancerCOVID-19 Clinical Research StudiesDiabetes Treatment and Management